Trial
NCT02920450
Study of Paclitaxel, Carboplatin, and PF-05212384 in Advanced or Metastatic NSCLC (UF-STO-LUNG-002)
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Florida
Collaborators
Pfizer
Condition
Non-Small Cell Lung Cancer
Intervention
Gedatolisib
Why stopped
Slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-10-04